Brennan: Pharma will not follow banking with industry standards
This article was originally published in Scrip
Executive Summary
AstraZeneca's chief executive David Brennan has played down the likelihood of a global industry standard being devised for the pharmaceutical sector, arguing that cultural and economic differences would make it too difficult to legislate.